A detailed history of Occidental Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Occidental Asset Management, LLC holds 10,021 shares of BMY stock, worth $563,380. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,021
Previous 9,135 9.7%
Holding current value
$563,380
Previous $379,000 36.68%
% of portfolio
0.08%
Previous 0.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$39.66 - $51.75 $35,138 - $45,850
886 Added 9.7%
10,021 $518,000
Q2 2024

Jul 15, 2024

BUY
$40.25 - $52.99 $25,639 - $33,754
637 Added 7.5%
9,135 $379,000
Q1 2024

Apr 16, 2024

SELL
$47.98 - $54.4 $66,212 - $75,072
-1,380 Reduced 13.97%
8,498 $460,000
Q4 2023

Jan 18, 2024

SELL
$48.48 - $57.85 $9,356 - $11,165
-193 Reduced 1.92%
9,878 $506,000
Q3 2023

Oct 18, 2023

SELL
$57.89 - $64.73 $86,835 - $97,095
-1,500 Reduced 12.96%
10,071 $584,000
Q4 2022

Jan 23, 2023

BUY
$68.48 - $81.09 $78,752 - $93,253
1,150 Added 11.04%
11,571 $0
Q2 2022

Jul 18, 2022

SELL
$72.62 - $79.98 $5,446 - $5,998
-75 Reduced 0.71%
10,421 $802,000
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $58,993 - $68,772
-1,100 Reduced 9.49%
10,496 $654,000
Q2 2021

Aug 17, 2021

SELL
$61.91 - $67.42 $15,353 - $16,720
-248 Reduced 2.09%
11,596 $775,000
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $784,296 - $882,102
-13,217 Reduced 52.74%
11,844 $748,000
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $29,216 - $33,107
506 Added 2.06%
25,061 $1.56 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $631 - $700
-11 Reduced 0.04%
24,555 $1.48 Million
Q2 2020

Jul 17, 2020

BUY
$54.82 - $64.09 $102,184 - $119,463
1,864 Added 8.21%
24,566 $1.44 Million
Q1 2020

Apr 23, 2020

BUY
$46.4 - $67.43 $586,171 - $851,843
12,633 Added 125.46%
22,702 $1.27 Million
Q4 2019

Jan 16, 2020

BUY
$49.21 - $64.19 $7,381 - $9,628
150 Added 1.51%
10,069 $646,000
Q3 2019

Oct 17, 2019

SELL
$42.77 - $50.71 $4,277 - $5,071
-100 Reduced 1.0%
9,919 $503,000
Q2 2018

Mar 19, 2019

SELL
$50.53 - $62.98 $101,060 - $125,960
-2,000 Reduced 16.64%
10,019 $554,000
Q2 2017

Mar 19, 2019

SELL
N/A
-150 Reduced 1.23%
12,019 $670,000
Q1 2017

Mar 19, 2019

SELL
N/A
-150 Reduced 1.22%
12,169 $662,000
Q2 2016

May 15, 2019

BUY
N/A
4,019 Added 48.42%
12,319 $906,000
Q4 2015

Jun 17, 2019

SELL
N/A
-100 Reduced 1.19%
8,300 $571,000
Q4 2014

Jun 17, 2019

SELL
N/A
-900 Reduced 9.68%
8,400 $496,000
Q1 2014

Jun 17, 2019

BUY
N/A
9,300
9,300 $483,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.